Results for &quot;&quot;PPAR delta&quot;&quot;[mesh_terms]

Emerging roles of PPARdelta in metabolism.

Udo Seedorf, Jens Aberle

Biochimica et biophysica acta 2007;1771(9):1125-31

C Allele of the PPARδ+294T>C Polymorphism Confers a Higher Risk of Hypercholesterolemia, but not Obesity and Insulin Resistance: A Systematic Review and Meta-Analysis.

Shujin Li, Youjin Zhang, Wenhao Xu, Zhimin Lv, Luying Xu, Zixuan Zhao, Dan Zhu, Yongyan Song

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2023;55(5):355-366

Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.

Nicole Wagner, Kay-Dietrich Wagner

Cells 2022;11(15):2432

Brazil Nut Supplementation Does Not Regulate PPARβ/δ Signaling Pathway in Peripheral Blood Mononuclear Cells from Coronary Artery Disease Patients.

Beatriz Oliveira da Cruz, Ludmila Ferreira Medeiros de Cardozo, Karen Salve Coutinho-Wolino, Claudio Tinoco Mesquita, Viviane Oliveira Leal, Denise Mafra, Milena Barcza Stockler-Pinto

Journal of the American Nutrition Association 2022;41(8):780-787

Dual acting and pan-PPAR activators as potential anti-diabetic therapies.

Monique Heald, Michael A Cawthorne

Handbook of experimental pharmacology 2011

Single- and multiple-dose safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of ASP0367, or bocidelpar sulfate, a novel modulator of peroxisome proliferator-activated receptor delta in healthy adults: Results from a phase 1 study.

Mototsugu Ito, Sitra Tauscher-Wisniewski, Ronald A Smulders, Tomasz Wojtkowski, Akihiro Yamada, Akira Koibuchi, Tolga Uz, Gerard J Marek, Ronald D Goldwater

Muscle & nerve 2022;65(1):110-120

Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.

Hubert Vidal, Bart Staels, Valérie Sauvinet, Martine Laville, Laurent Flet, Stéphanie Lambert-Porcheron, Bertrand Cariou, Rémy Hanf, Yassine Zaïr, Benoit Noël

Diabetes care 2014;36(10):2923-30

Pharmacokinetics of Bocidelpar, ASP0367, in Renal and Hepatic Impairment: Results From Two Phase 1 Studies.

Nakyo Heo, Megumi Iwai, Selina Moy, Kentaro Hashimoto, Tomasz Wojtkowski, Tong Zhu, Sayuri Guro, Anna Spence, Lauren Benner, Melanie Helmick, Brian C Ferslew

Clinical and translational science 2025;18(8):e70310

Elafibranor modulates ileal macrophage polarization to restore intestinal integrity in NASH: Potential crosstalk between ileal IL-10/STAT3 and hepatic TLR4/NF-κB axes.

Basma A Abdelrahman, Andrew N Hakeem, Mohamed M Kamal, Rasha A Tawfiq, Olfat A Hammam, Mohamed M Elmazar, Aiman S El-Khatib, Yasmeen M Attia

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022;157():114050

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.

J F Deeken, T Cormier, D K Price, T M Sissung, S M Steinberg, K Tran, D J Liewehr, W L Dahut, X Miao, W D Figg

The pharmacogenomics journal 2010;10(3):191-9

Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism.

Eric Bruckert, Bart Staels, Yassine Zaïr, Bertrand Cariou

Diabetes care 2012;34(9):2008-14

Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population.

H D Ye, Y R Li, Q X Hong, A N Zhou, Q L Zhao, L M Xu, M Q Xu, X T Xu, L L Tang, D J Dai, D J Jiang, Y Huang, D W Wang, S W Duan

Genetics and molecular research : GMR 2016;14(2):6350-9

Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity.

Grant D Barish

The Journal of nutrition 2006;136(3):690-4

Effect of caffeine on mitochondrial biogenesis in the skeletal muscle - A narrative review.

Craig Pickering, André K Yamada, Gustavo D Pimentel, André V Cordeiro, Vagner R R Silva

Clinical nutrition ESPEN 2022;51():1-6